Brielle Benyon

Articles by Brielle Benyon

The FDA approved pralsetinib (Gavreto) for adults and children aged 12 or older with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who need systemic therapy or RET fusion-positive thyroid cancer who require systemic therapy and are radioactive iodine-refractory.

In this episode, we spoke with Brown, a nurse and best-selling author, about her recent online petition to have a nurse on president-elect Joe Biden’s COVID-19 task force. She said that now, more than ever, it is vital for nurses to have their voices heard.

The FDA granted an accelerated approval to pembrolizumab (Keytruda) plus chemotherapy for the treatment of patients with locally recurrent, unresectable or metastatic triple-negative breast cancer (TNBC) with PD-L1 expression is CPS ≥10, according to the agency.